ArticleAbdominal radiology (New York)2025
Bilateral adrenal heterogeneity in contrast-enhanced CT for differentiating nodule-negative primary aldosteronism.
Article in Abdominal radiology (New York), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveIn nodule-negative primary aldosteronism (PA), quantitative CT findings in unilateral PA differed from those in bilateral PA. We attempted to identify PA by quantitative parameters of contrast-enhanced CT.
methodsA retrospective search was performed for 81 patients with nodule-negative PA who underwent contrast-enhanced CT between January 2021 and November 2024 and adrenal vein sampling thereafter at XXXX. The test cohort and validation cohort were enrolled separately based on the PA type. The optimal cutoff value for identifying PA was analyzed and calculated in the test cohort, and its diagnostic performance was subsequently evaluated in the validation cohort.
resultsIn the venous phase of the test cohort, the SD difference or ratio was significantly higher in unilateral-left PA than in bilateral PA [SD difference: 6.3 (4.4, 8.8) Hu vs. 2.5 (1.5, 4.4) Hu, P < 0.001; SD ratio: 1.2 (1.1, 1.3) vs. 1.1 (1.0, 1.1), P < 0.001]. At a cutoff value of 4.90 Hu, the sensitivity and specificity of the SD difference in predicting PA type were 0.733 and 0.957, respectively. The sensitivity and specificity of the SD ratio were 0.867 and 0.723 at a cutoff value of 1.130, respectively. In the validation cohort, the diagnostic performance of the SD difference in identifying PA type was similar to that of the SD ratio (0.801 vs. 0.917, P = 0.06).
conclusionPatients with nodule-negative PA can be further differentiated by bilateral adrenal heterogeneity on contrast-enhanced CT. The SD difference has similar predictive ability as the SD ratio.
Indexed as
Identifiers
40464845What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.